Jill A. Gallaher

This paper develops and validates a treatment strategy called evolutionary antifragile therapy, which uses treatment fluctuations to limit tumor resistance evolution.

This paper uses agent-based models to analyze how metastatic tumor dynamics inform adaptive therapy schedules and identifies how tumor heterogeneity affects treatment outcomes.

The paper introduces the Hybrid Automata Library (HAL), a Java platform for building hybrid models in mathematical oncology, with real-time visualization and modular components.

The paper introduces a hybrid method to estimate parameters in agent-based models using glioblastoma data to improve model calibration.